메뉴 건너뛰기




Volumn 369, Issue 3, 2013, Pages 209-211

Communicating and promoting comparative-effectiveness research findings

Author keywords

[No Author keywords available]

Indexed keywords

COMPARATIVE EFFECTIVENESS; DRUG INDUSTRY; DRUG MARKETING; EVIDENCE BASED PRACTICE; FOOD AND DRUG ADMINISTRATION; GOVERNMENT REGULATION; HEALTH CARE POLICY; HUMAN; MASS COMMUNICATION; MEDICAL INFORMATION; MEDICAL RESEARCH; PRIORITY JOURNAL; PRODUCT SAFETY; PUBLIC HEALTH; SHORT SURVEY;

EID: 84880444143     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1300312     Document Type: Article
Times cited : (14)

References (5)
  • 1
    • 84871966670 scopus 로고    scopus 로고
    • Regulatory requirements of the Food and Drug Administration would preclude product claims based on observational research
    • Millwood
    • Griffin JP, Godfrey BM, Sherman RE. Regulatory requirements of the Food and Drug Administration would preclude product claims based on observational research. Health Aff (Millwood) 2012;31:2188-92.
    • (2012) Health Aff , vol.31 , pp. 2188-2192
    • Griffin, J.P.1    Godfrey, B.M.2    Sherman, R.E.3
  • 2
    • 84871959499 scopus 로고    scopus 로고
    • The Food and Drug Administration has the legal basis to restrict promotion of flawed comparative effectiveness research
    • Millwood
    • Kesselheim AS, Avorn J. The Food and Drug Administration has the legal basis to restrict promotion of flawed comparative effectiveness research. Health Aff (Millwood) 2012;31:2200-5.
    • (2012) Health Aff , vol.31 , pp. 2200-2205
    • Kesselheim, A.S.1    Avorn, J.2
  • 4
    • 79960122828 scopus 로고    scopus 로고
    • FDA Modernization Act, section 114: Uses, opportunities and implications for comparative effectiveness research
    • Neumann PJ, Lin PJ, Hughes TEUS. FDA Modernization Act, section 114: uses, opportunities and implications for comparative effectiveness research. Pharmacoeconomics 2011;29:687-92.
    • (2011) Pharmacoeconomics , vol.29 , pp. 687-692
    • Neumann, P.J.1    Lin, P.J.2    Hughes, T.E.U.S.3
  • 5
    • 84866403853 scopus 로고    scopus 로고
    • FDA actions against health economic promotions, 2002-2011
    • Neumann PJ, Bliss SK. FDA actions against health economic promotions, 2002-2011. Value Health 2012;15:948-53.
    • (2012) Value Health , vol.15 , pp. 948-953
    • Neumann, P.J.1    Bliss, S.K.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.